๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Randomised clinical trial: comparison of two everolimus dosing schedules in patients with advanced hepatocellular carcinoma

โœ Scribed by Shiah, H.-S.; Chen, C.-Y.; Dai, C.-Y.; Hsiao, C.-F.; Lin, Y.-J.; Su, W.-C.; Chang, J.-Y.; Whang-Peng, J.; Lin, P.-W.; Huang, J.-D.; Chen, L.-T.

Book ID
119826697
Publisher
John Wiley and Sons
Year
2012
Tongue
English
Weight
262 KB
Volume
37
Category
Article
ISSN
0269-2813

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Ifosfamide, paclitaxel, and cisplatin fo
Ifosfamide, paclitaxel, and cisplatin for patients with advanced transitional cell carcinoma of the urothelial tract : Final report of a Phase II trial evaluating two dosing schedules
โœ Dean F. Bajorin; John A. McCaffrey; Paul M. Dodd; Susan Hilton; Madhu Mazumdar; ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 88 KB ๐Ÿ‘ 2 views

## BACKGROUND. A combination regimen of ifosfamide, paclitaxel, and cisplatin (ITP), recycled every 4 weeks, was reported in the treatment of previously untreated patients with advanced transitional cell carcinoma (TCC). This study sought to examine ITP at 3-week intervals to assess its feasibility